nextgener
vaccin
util
cell
could
potenti
overcom
limit
current
influenza
vaccin
reli
antibodi
provid
narrow
subtypespecif
protect
prone
antigen
mismatch
circul
strain
evid
anim
model
show
cell
provid
heterosubtyp
protect
crucial
immun
control
influenza
viru
infect
provid
hope
design
univers
vaccin
abl
prime
divers
influenza
viru
strain
subtyp
howev
multipl
hurdl
exist
realis
univers
cell
vaccin
overal
primari
concern
extrapol
human
clinic
studi
seed
durabl
effect
cell
resid
memori
trm
popul
human
leucocyt
antigen
hla
coverag
potenti
cellmedi
immun
escap
comprehens
human
clinic
data
need
natur
infect
valid
protect
role
cell
play
infect
absenc
antibodi
furthermor
fundament
question
still
exist
regard
site
longev
durat
quantiti
phenotyp
cell
need
optim
protect
standardis
experiment
method
eventu
simplifi
commerci
assay
assess
peripher
influenzaspecif
cell
respons
need
largerscal
clinic
studi
cell
correl
protect
influenza
infect
design
implement
cellinduc
vaccin
requir
consensu
level
protect
accept
commun
may
provid
steril
immun
could
protect
individu
sever
diseas
reduc
length
infect
potenti
reduc
transmiss
commun
therefor
increas
standard
care
potenti
offer
cell
vaccin
consid
context
pandem
prepared
zoonot
infect
combin
improv
antibodi
vaccin
target
method
current
pandem
vaccin
prepared
measur
ongo
clinic
trial
underutilis
cellinduc
vaccin
reflect
myriad
question
remain
cell
need
fight
influenza
viru
infect
review
aim
bring
togeth
basic
fundament
cell
biolog
human
clinic
data
need
consid
implement
univers
vaccin
influenza
har
power
cell
countless
exampl
exist
influenza
virus
caus
havoc
public
health
perpetu
season
epidem
worldwid
pandem
zoonot
infect
anim
reservoir
yet
current
vaccin
method
arm
us
divers
influenza
virus
influenza
vaccin
wide
use
vaccin
world
million
dose
use
annual
due
season
epidem
recommend
annual
vaccin
howev
efficaci
inactiv
influenza
vaccin
iiv
moder
poor
impact
antigen
drift
mismatch
pandem
emerg
due
reassort
egg
adapt
vaccin
product
lead
reduc
protect
increas
incid
infect
efficaci
live
attenu
influenza
vaccin
laiv
mainli
recommend
use
childrenha
also
drop
recent
year
possibl
due
thermal
stabil
issu
antigen
competit
prime
overal
factor
culmin
reduc
public
confid
influenza
vaccin
current
vaccin
stockpil
avian
influenza
virus
reduc
immunogen
compar
season
influenza
virus
requir
multipl
dose
use
adjuv
may
match
futur
emerg
version
virus
pandem
show
abl
respond
fact
monoval
pandem
vaccin
becam
avail
peak
human
infect
leav
major
popul
ride
storm
public
outcri
spectr
pandem
sever
predict
vaccin
product
method
significantli
ramp
wake
pandem
time
viru
isol
distribut
largescal
product
encount
similar
issu
futur
pandem
overal
substanti
revitalis
current
vaccin
program
need
combat
influenza
virus
overcom
vaccin
product
limit
prearm
divers
diverg
influenza
virus
vaccin
educ
adapt
immun
systemspecif
b
cellsfor
faster
stronger
specif
respons
upon
reencount
match
antigen
howev
current
iiv
laiv
effici
induc
cell
immun
potenti
contribut
limit
efficaci
breadth
reactiv
divers
influenza
virus
importantli
current
inactiv
influenza
vaccin
tend
prevent
induct
crossreact
tcell
would
otherwis
elicit
natur
influenza
viru
infect
primari
protect
case
vaccin
mismatch
pandem
outbreak
figur
cell
express
clonal
cell
receptor
tcr
recogn
linear
fragment
viral
peptid
amino
acid
long
present
major
histocompat
complex
mhc
molecul
surfac
infect
cell
antigen
present
cell
access
mhc
present
pathway
utilis
endogen
direct
present
exogen
crosspresent
deriv
peptid
gener
cleavag
viral
protein
immunoproteasom
process
import
implic
vaccin
approach
need
consid
design
deliveri
antigen
pathway
activ
cell
viral
entri
translat
requir
access
mhc
process
machineri
howev
peptid
present
preced
viru
replic
protein
composit
immunodomin
hierarchi
subsequ
cell
respons
predominantli
reflect
abund
virion
protein
express
infect
time
express
memori
cell
provid
effect
heterosubtyp
immun
wherebi
cell
abl
recognis
differ
even
unrel
influenza
virus
due
peptid
homolog
conserv
linear
peptid
sequenc
differ
strain
subtyp
influenza
heterosubtyp
cell
immun
especi
import
exist
antibodi
respons
occur
season
antigen
drift
zoonot
infect
pandem
situat
protect
efficaci
crossreact
cell
demonstr
extens
anim
studi
mice
ferret
exampl
mice
prime
viru
boost
final
challeng
high
dose
lethal
viru
detect
viru
replic
thu
unlik
major
b
cell
cell
capabl
expand
immunolog
protect
divers
influenza
virus
although
antibodymedi
immun
elicit
natur
infect
current
vaccin
strategi
capabl
provid
steril
protect
protect
gener
primarili
hemagglutinin
ha
neuraminidas
na
epitop
viru
surfac
immun
escap
common
surfac
antigen
via
modif
glycan
amino
acid
substitut
key
antigen
site
intern
protein
constrain
function
limit
viral
fit
lee
et
al
identifi
cell
peptid
epitop
crossrecognis
season
virus
cell
one
deriv
ha
surfac
protein
major
cell
epitop
deriv
intern
protein
conserv
rate
differ
iav
strain
subtyp
whilst
ha
na
surfac
protein
conserv
differ
iav
subtyp
inde
cell
crossreact
highli
pathogen
avian
influenza
virus
found
peripher
blood
unexpos
healthi
volunt
furthermor
robust
expedi
recruit
crossreact
cell
memori
correl
improv
infect
outcom
faster
recoveri
surviv
infect
influenza
b
virus
share
mani
featur
littl
sequenc
ident
analog
protein
rang
amino
acid
ident
except
polymeras
basic
protein
amino
acid
ident
despit
broadli
neutral
monoclon
antibodi
highli
conserv
ha
na
epitop
influenza
b
virus
report
review
addit
conserv
cell
epitop
ha
fusion
peptid
influenza
b
virus
elicit
crossreact
cell
human
number
wellcharacter
cell
epitop
protein
show
complet
amino
acid
conserv
slight
variat
amongst
influenza
b
virus
hint
possibl
truli
univers
paninfluenza
b
viru
cell
immun
could
har
vaccin
area
research
cell
crossreact
beyond
influenza
virus
current
remain
underexplor
cell
repres
famili
phenotyp
divers
subtyp
term
function
locat
magnitud
cytotox
cell
recogn
viral
peptid
context
mhc
class
mhci
express
surfac
nucleat
cell
allow
immun
surveil
cell
mediat
direct
lysi
virusinfect
cell
produc
antivir
cytokin
effect
directli
reduc
viral
load
length
infect
meanwhil
helper
cell
recogn
viral
peptid
within
mhc
class
ii
mhcii
express
profession
antigen
present
cell
b
cell
macrophag
dendrit
cell
cell
helper
cell
critic
cornerston
establish
effect
immun
memori
influenza
viru
infect
necessari
establish
cell
memori
respons
high
avid
class
switch
antibodi
review
addit
propos
mhcii
also
express
type
ii
alveolar
pneumocyt
infect
enabl
cell
target
minor
popul
infect
cell
lung
tissu
direct
cytotox
mechan
cell
express
clonal
divers
highli
specif
tcr
cell
surfac
tcr
consist
chain
heterodim
fine
specif
antigen
recognit
provid
somat
recombin
nongermlin
encod
addit
complementar
determin
region
cdr
chain
estim
divers
human
cell
repertoir
distinct
tcr
whilst
tcr
divers
individu
epitopespecif
cell
respons
oligoclon
compos
differ
distinct
tcr
sequenc
unlik
antibodi
respons
tcr
undergo
affin
matur
thymu
involut
puberti
greatli
diminish
output
cell
age
capac
heterolog
immun
cell
respons
imper
protect
huge
array
possibl
pathogen
encount
lifetim
outnumb
tcr
repertoir
therefor
overlap
tcr
specif
necess
heterolog
cell
protect
differ
epitop
report
mice
lcmv
vaccinia
viru
pichind
viru
human
influenza
hepat
c
viru
papilloma
virus
coronavirus
influenza
epsteinbarr
viru
ebv
dengu
subtyp
discuss
differ
strain
influenza
variant
immunodomin
influenzaderiv
epitop
cell
deriv
bone
marrow
progenitor
cell
matur
develop
thymu
undergo
posit
neg
select
process
emigr
nonselfreact
immatur
cell
peripheri
immun
surveil
cell
express
alter
nonselfantigen
immatur
cell
circul
secondari
lymphoid
organ
survey
cognat
antigen
matur
memori
subsetsdepend
phenotyp
prime
signalscan
resid
tissu
parenchyma
cell
resid
memori
trm
lymph
node
cell
central
memori
tcm
peripheri
cell
effector
memori
tem
cell
recognit
peptidemhc
context
signal
eg
costimul
inflammatori
cytokin
lead
cell
activ
prolifer
differenti
amplifi
effect
armi
cell
infect
number
epitopespecif
cell
estim
mous
model
immunodomin
subdomin
epitop
cellsmous
cellsmous
respect
effici
recruit
pool
cell
respond
acut
infect
depend
numer
factor
peptid
context
mhc
allel
restrict
antigen
present
cell
time
antigen
express
viru
life
cycl
avid
tcr
peptidemhc
interact
review
tcr
engag
recruit
activ
cell
amplifi
acut
stage
infect
rapid
expans
peak
magnitud
virusspecif
cell
coincid
drastic
reduct
viral
titr
day
primari
viru
infect
wherea
influenzaspecif
antibodi
peak
plateau
day
post
infect
follow
antigen
clearanc
day
post
influenza
infect
antigenspecif
cell
pool
contract
wherebi
differenti
cell
undergo
activationinduc
cell
death
apoptosi
leav
behind
stabilis
memori
pool
kinet
cell
respons
human
influenza
infect
variabl
studi
report
rapid
peak
virusspecif
cell
oneweek
postinfect
subsequ
contract
within
week
infect
other
suggest
protract
respons
dynam
peak
week
infect
modest
declin
cell
number
day
return
baselin
day
extent
variat
dynam
reflect
differ
viru
strain
infect
sever
individu
characterist
host
respons
remain
determin
cell
memori
pool
remain
infect
estim
halflif
year
human
remark
detect
year
post
smallpox
vaccin
lifespan
influenzaspecif
cell
track
past
year
due
repeat
encount
influenza
viru
infect
make
track
difficult
time
multipl
dose
laivsand
iiv
subunit
influenza
vaccinescan
induc
longliv
broad
protect
immun
respons
mice
therefor
laiv
appear
immunogen
anim
studi
howev
human
respons
laiv
dispar
depend
age
laiv
seem
effect
iiv
children
adult
coincid
boost
cellular
immun
possibl
result
children
immun
state
result
robust
primari
cellular
immun
respons
laivinduc
humor
cellular
immun
could
maintain
least
one
year
longev
beyond
year
studi
far
laiv
vaccin
current
limit
efficaci
report
vaccin
efficaci
laiv
vs
iiv
report
howev
laiv
sincer
attempt
cellinduc
vaccin
nasal
deliveri
appear
mild
reduc
tissu
tropism
inflamm
far
fail
increas
cellular
immun
improv
vaccin
efficaci
adult
therefor
futur
univers
vaccin
must
improv
upon
laiv
either
use
immunogen
vaccin
vector
delet
adenoviru
mva
adjuv
less
attenu
influenza
virus
use
codon
bia
mutant
mutant
hasign
peptid
virus
lesson
learn
limit
efficaci
immunogen
laiv
human
studi
develop
nextgener
univers
vaccin
cell
oper
isol
synergi
multipl
immun
mechan
provid
broad
heterosubtyp
protect
figur
heterolog
protect
mediat
crossreact
cell
shown
depend
interact
macrophag
fcrdepend
nonneutr
antibodi
similar
inexplic
protect
rate
beyond
cell
respons
magnitud
observ
laiv
thailandphilippin
clinic
trial
addit
time
recruit
memori
cell
cell
nk
cell
neutral
antibodi
impact
infect
outcom
cell
type
also
contribut
heterolog
protect
mucos
associ
invari
mait
cell
fcr
cell
recruit
cell
respons
thu
next
gener
cell
vaccin
combin
multipl
immun
respons
heterolog
protect
effect
heterolog
immun
zoonot
influenza
virus
requir
synergi
multipl
immun
arm
without
recruit
two
immun
arm
protect
immun
diminish
model
outcom
infect
patient
although
multipl
arm
like
activ
time
hospit
patient
clearli
demonstr
differ
arm
promin
role
one
arm
fail
respond
mait
mucos
associ
invari
cell
phenotyp
divers
depend
surfac
receptor
cytokin
express
characteris
numer
subset
treg
follicular
helper
tfh
review
cell
field
less
develop
cell
field
review
influenza
research
due
avail
mhci
tetram
transgen
mous
strain
howev
continu
effort
use
adapt
method
peptid
scan
whole
viru
identif
influenzaspecif
cell
reveal
intrins
necess
heterolog
protect
influenza
viru
infect
characterist
type
cell
secret
necessari
format
cell
memori
capabl
recal
tfh
cell
induct
high
affin
class
switch
b
cell
memori
induct
hastemspecif
antibodi
requir
highli
develop
bcell
receptor
sequenc
undergon
affin
matur
like
coordin
follicular
helper
tfh
cell
immun
current
iiv
activ
tfh
cell
correl
increas
number
peripher
antibodysecret
memori
b
cell
emerg
bodi
work
demonstr
critic
role
tfh
cell
play
shape
antibodi
profil
wherebi
conserv
nucleoprotein
np
specif
tfh
cell
compet
haspecif
tfh
cell
result
reduc
antibodi
recal
respons
prime
therefor
order
prime
establish
immunodomin
hierarchi
tfh
respons
impact
develop
hastem
antibodi
germin
centr
interplay
proteinspecif
order
immun
memori
imprint
import
context
human
immun
memori
heterogen
individualist
depend
subject
exposur
background
imprint
hasubtyp
specif
cell
b
cell
memori
epidemiolog
impact
haimprint
recent
describ
epidemiolog
model
explain
age
associ
infect
provid
protect
sever
infect
caus
virus
attribut
individu
first
hagroup
encount
result
age
distribut
case
born
correspond
switch
phylogenet
group
includ
ha
subtyp
group
includ
ha
subtyp
ha
hong
kong
pandem
furthermor
addit
helper
function
influenzaspecif
cell
may
imper
protect
heterolog
influenza
infect
transgen
mous
model
cell
also
found
directli
cytotox
influenza
infect
human
influenzaspecif
cell
express
granzym
perforin
exhibit
kill
function
correl
reduc
sever
infect
viral
load
furthermor
cellinduc
vaccin
mous
model
identifi
deplet
memori
cell
cell
compart
remov
heterolog
protect
lethal
influenza
challeng
new
role
continu
emerg
key
role
influenzaspecif
cell
play
heterolog
infect
overal
influenzaspecif
cell
cornerston
effect
influenza
respons
role
dynam
interplay
recal
heterolog
b
cell
respons
infect
outcom
figur
longterm
role
imprint
cell
memori
respons
univers
vaccin
import
implic
futur
vaccin
design
yet
fulli
explor
epidemiolog
studi
past
influenza
pandem
absenc
neutral
antibodi
suggest
cellmedi
immun
provid
heterosubtyp
protect
howev
complex
involv
conduct
studi
ie
obtain
right
cohort
preexist
antibodi
respons
sampl
prior
infect
mean
direct
evid
role
cell
influenza
viru
infect
human
limit
major
challeng
univers
vaccin
field
determin
strength
cellmedi
correl
protect
unlik
anim
model
influenza
viru
infect
human
result
wide
spectrum
symptom
reflect
either
upper
lower
respiratori
tract
involv
clinic
diseas
epidemiolog
also
distinct
season
avian
influenza
case
thu
practis
definit
protect
human
studi
vari
studi
studi
gener
meant
reduct
viru
shed
manifest
symptom
symptom
either
selfreport
observ
clinic
determin
season
influenza
earliest
direct
evid
cell
mediat
protect
facilit
viru
clearanc
infect
shown
human
challeng
studi
thirti
year
later
sridhar
et
al
took
advantag
exist
communitywid
cohort
show
within
context
natur
infect
pandem
demonstr
magnitud
subset
cell
strongli
correl
reduc
diseas
sever
infect
cell
also
shown
lateeffector
memori
cell
contrast
find
earlier
experiment
human
challeng
studi
cell
correl
reduc
viral
load
diseas
symptom
instead
cell
memori
respons
discrep
attribut
differ
experiment
design
ie
viru
challeng
use
laboratorygrown
virus
hemagglutin
inhibit
hai
neg
subject
versu
natur
pandem
infect
serv
highlight
challeng
associ
studi
cell
respons
human
cell
recogn
highli
conserv
viral
protein
great
interest
investig
protect
role
human
case
avian
influenza
viru
infect
numer
studi
demonstr
presenc
crossreact
cell
avian
influenza
virus
vitro
actual
evid
protect
infect
diseas
field
still
lack
sinc
sporad
virul
natur
avian
influenza
case
preclud
systemat
cohort
studi
studi
date
observ
base
rel
small
number
case
outbreak
china
studi
suggest
earli
induct
recruit
memori
cell
associ
improv
prognosi
contrast
cellular
immun
data
scarc
numer
studi
investig
cytokin
profil
infect
human
prognost
marker
signatur
correl
protect
proinflammatori
cytokin
interleukin
il
chemotact
regul
innat
immun
cell
commonli
induc
acut
phase
diseas
howev
cytokin
import
induc
respons
also
report
depress
sever
ill
individu
particular
interest
regul
downstream
concentr
cytokin
lower
sever
season
avian
influenza
case
incident
also
lower
level
peripher
cell
compar
mild
influenza
case
howev
role
cytokin
need
valid
sinc
data
murin
model
suggest
high
level
cytokin
suppress
format
lung
memori
cell
airway
state
current
knowledg
influenza
cell
respons
human
still
tri
catch
lesson
learn
anim
model
vitro
murin
studi
demonstr
cell
mediat
lung
patholog
review
primarili
hypersecret
solubl
factor
caus
direct
lysi
bystand
damag
lung
milieu
although
immunemedi
patholog
certainli
suggest
import
compon
sever
influenza
infect
human
definit
causal
role
cell
uncoupl
innat
immun
viral
factor
still
lack
inde
cytokin
associ
cellular
innat
immun
appear
better
predictor
influenza
diseas
sever
studi
cell
respons
human
conduct
within
peripher
compart
due
eas
sampl
access
howev
peripher
airway
mucos
immun
alway
concord
respiratori
infect
furthermor
viral
replic
persist
lower
respiratori
tract
without
detect
upper
respiratori
tract
nasal
swab
often
collect
detect
viral
rna
airway
sampl
difficult
collectparticularli
lower
respiratori
tract
nasal
swab
contain
mucos
inhibitor
low
cellular
inappropri
cellular
immun
studi
nasal
aspir
rare
human
influenza
studi
furthermor
sampl
lower
respiratori
tract
bronchoalveolar
lavag
often
ethic
preclud
healthi
adult
therefor
studi
local
respiratori
tissu
cell
immun
limit
sever
infect
case
compar
infect
outcom
rather
protect
infect
diseas
rare
studi
data
avail
number
influenzaspecif
cell
well
magnitud
cytokin
respons
far
greater
lung
compar
blood
homolog
viru
challeng
ferret
receiv
monoval
aviet
vaccin
show
cell
airway
blood
correl
earli
viral
clearanc
eleg
studi
murin
model
identifi
cell
popul
airway
tissu
resid
memori
cell
see
section
phenotyp
function
distinct
blood
also
identifi
human
howev
like
peripher
compart
continu
proxi
evalu
cell
respons
human
extent
accur
peripher
cell
respons
reflect
airway
crucial
translat
shortand
longterm
protect
import
consider
effect
cellmedi
vaccin
develop
adult
baselin
level
detect
influenzaspecif
cell
effort
made
quantit
identifi
cellmedi
protect
threshold
correl
protect
studi
involv
children
thailand
philippin
forrest
et
al
report
receiv
twodos
laiv
haiseroneg
children
spotform
unit
sfu
pbmc
assay
use
inactiv
vaccin
compon
antigen
protect
symptomat
diseas
subsequ
infect
studi
also
made
two
notabl
observ
protect
threshold
studi
popul
two
countri
differ
ii
mechan
protect
attribut
measur
respons
note
increas
vaccin
dosag
thu
attempt
provid
quantit
correl
protect
studi
also
highlight
popul
heterogen
cell
compart
import
immunemechan
ie
mediat
cell
nonhaireact
antibodi
miss
experiment
approach
recent
studi
hayward
et
al
chose
focu
immunodomin
respons
influenza
np
rather
haspecif
cell
respons
report
pbmc
associ
reduc
viral
shed
communityacquir
influenza
final
sridhar
et
al
use
statist
model
predict
everi
increas
cell
frequenc
enumer
elispot
associ
reduct
risk
develop
febril
influenza
differ
assay
use
across
three
studi
difficult
interpret
import
quantifi
find
corrobor
worth
note
studi
evalu
symptomat
case
evid
role
cell
asymptomat
casesparticularli
within
commun
settingi
still
lack
clinic
evid
thu
far
support
role
exist
cellsparticularli
populationin
reduc
symptom
sever
howev
heterogen
experiment
design
ie
studi
definit
endpoint
use
use
differ
unqualifi
assay
measur
cell
respons
elispot
method
directli
compar
differ
studi
seem
suggest
phenomenon
blind
men
eleph
wherebi
studi
measur
cell
respons
immun
correl
differ
way
sometim
provid
dispar
conclus
integr
myriad
clinic
find
identifi
singl
quantifi
trait
cell
correl
protect
remain
major
challeng
issu
surmount
sophist
studi
design
research
otherssuch
airway
cell
responsesmay
remain
challeng
address
human
thu
addit
understand
basic
biolog
field
must
also
work
develop
robust
system
includ
standard
qualifi
cell
assay
use
human
studi
date
vaccin
intend
elicit
cell
immun
viral
infect
gener
disappoint
level
protect
provok
recent
reassess
variabl
import
success
gener
cellmedi
immun
quantiti
locat
memori
cell
popul
consid
critic
import
cell
requir
contact
target
cell
mediat
cytolyt
function
word
act
local
therefor
effect
cellbas
vaccin
target
earliest
stage
infect
would
requir
deposit
signific
number
memori
cell
local
within
mucos
tissu
nonlymphoid
tissu
hous
larg
proport
memori
cell
pool
previous
thought
simpli
circul
memori
cell
traffick
tissu
part
immunolog
surveil
howev
accept
major
cell
present
within
tissu
fact
resid
repres
distinct
memori
cell
popul
peripher
deposit
memori
cellsterm
tissu
resid
memori
trm
play
critic
role
local
immun
protect
directli
kill
pathogeninfect
cell
releas
cytokin
render
surroundingloc
environ
nonpermiss
pathogen
replic
promot
recruit
immun
cell
circul
cell
lineag
form
trm
distinguish
circul
memori
cell
due
express
key
surfac
marker
trm
upregul
express
trm
also
express
well
chain
integrin
although
trm
cell
also
detect
thu
altern
marker
trm
need
memori
cell
subset
equal
protect
influenza
viru
infect
trm
pool
shown
absolut
indispens
provid
optim
heterosubtyp
immun
figur
follow
secondari
encount
influenza
viru
lung
trm
rapidli
acquir
effector
function
respond
swiftli
mediat
enhanc
viral
clearanc
surviv
lethal
influenza
infect
trm
provid
superior
protect
influenza
viru
infect
simpli
right
place
right
time
influenza
viru
gain
entri
bodi
inhal
initi
replic
cycl
within
respiratori
tract
earli
stage
infect
viru
titr
low
infect
host
provid
ideal
window
opportun
effect
immun
respons
limit
diseas
progress
trm
deposit
along
respiratori
tract
perfectli
situat
combat
earliest
stage
influenza
infect
human
lung
harbour
larg
number
memori
cell
signific
proport
express
molecular
signatur
phenotyp
profil
trm
cell
vast
major
influenzaspecif
memori
cell
present
within
human
lung
tissu
adopt
trm
phenotyp
differenti
influenzaspecif
cell
trm
import
longterm
mainten
find
size
influenzaspecif
cell
popul
persist
within
lung
directli
correl
effici
cell
differenti
trm
influenza
virusspecif
trm
shown
highli
prolif
polyfunct
molecular
profil
reveal
human
lung
trm
constitut
express
high
transcript
level
numer
cytotox
mediat
deploymentreadi
mrna
encod
effector
molecul
reflect
cell
pois
rapid
respons
influenza
virusspecif
trm
human
lung
tissu
also
maintain
divers
tcr
profilesa
featur
import
effect
cell
function
protect
gener
viralescap
mutant
influenzaspecif
pulmonari
trm
core
compon
natur
heterosubtyp
immun
develop
follow
exposur
influenza
viru
figur
thu
influenza
vaccin
design
impart
optim
heterosubtyp
immun
evok
memori
cell
subset
defin
paramet
promot
trm
format
along
respiratori
tract
critic
step
toward
develop
vaccin
current
know
factor
drive
trm
exposur
transform
growth
well
downregul
factor
tbet
eom
express
upregul
hobit
propos
univers
trm
development
requir
tissu
includ
lung
brain
trm
develop
also
depend
local
cognat
antigen
recognit
ration
design
vaccin
specif
evok
trm
iwasaki
colleagu
publish
first
vaccin
regim
specif
evok
trm
site
potenti
viral
exposurethey
coin
vaccin
regim
primepul
approach
reli
two
step
convent
parenter
vaccin
elicit
system
cell
respons
prime
follow
topic
applic
inflammatori
agent
lure
pull
cell
tissu
could
differenti
trm
primepul
vaccin
strategi
proven
effect
lodg
highlyprotect
trm
pool
skin
reproduct
tract
approach
effect
deposit
trm
cell
within
lung
trm
differenti
lungunlik
skin
reproduct
tractrequir
local
cognat
antigen
recognit
extens
primepul
vaccin
regim
incorpor
local
deliveri
cognat
antigen
develop
pulmonari
trm
vaccin
strategi
sever
group
use
varieti
modifi
primepul
vaccin
approach
includ
intranas
immun
influenza
peptideprotein
alon
load
onto
dendrit
cell
ii
intranas
deliveri
nonrepl
influenza
viru
iii
intranas
immun
monoclon
antibodi
link
influenza
antigen
target
antigen
respiratori
dendrit
cell
abl
success
gener
lung
trm
highli
protect
influenza
viru
challeng
collect
vaccin
studi
demonstr
key
induc
pulmonari
trm
local
intranas
administr
vaccin
antigen
figur
strategi
might
also
benefici
optim
antiinfluenza
antibodi
respons
induct
mucos
secretori
iga
respiratori
tract
vaccin
strategi
deposit
influenza
virusspecif
trm
cell
lung
provid
exquisit
protect
heterosubtyp
influenza
challeng
unfortun
protect
transient
unlik
popul
skin
intestin
mucosa
trm
cell
lung
undergo
attrit
result
increas
apoptosi
mous
model
confirm
within
month
deposit
influenza
virusspecif
lung
trm
decay
numer
threshold
leav
lung
suscept
reinfect
observ
decay
lung
trm
cell
mice
reason
complet
dismiss
potenti
provid
longterm
immun
human
mous
lung
trm
decay
necessarili
mean
human
lung
trm
also
undergo
rapid
rate
attrit
recent
studi
ahm
colleagu
util
vivo
deuterium
label
assess
human
memori
cell
turnov
longev
show
longev
circul
memori
cell
subset
human
reflect
lifespan
cell
mice
import
determin
lifespan
turnov
rate
human
lung
trm
cell
incorpor
vaccin
respiratori
pathogen
provid
durabl
vaccin
memori
determin
vaccin
schedul
maintain
protect
nonetheless
lung
trm
erod
counterpart
upper
respiratori
tract
form
stabl
longliv
memori
cell
pool
influenzaspecif
nasal
tissu
trm
effect
limit
local
replic
influenza
viru
block
transmiss
influenza
viru
upper
respiratori
tract
lung
prevent
develop
sever
pulmonari
diseas
cell
potenti
provid
longterm
immun
influenza
viru
protect
global
influenza
viru
need
think
local
trm
locat
along
respiratori
tract
perfectli
situat
mediat
rapid
protect
follow
inhal
influenza
viru
capabl
provid
potent
protect
inhal
pathogen
influenza
vaccin
design
impart
heterosubtyp
immun
evok
memori
cell
subset
best
induc
influenza
virusspecif
trm
along
respiratori
tract
vaccin
one
challeng
address
come
year
major
antigen
target
influenzaspecif
cell
epitop
deriv
highli
conserv
intern
viru
protein
provid
basi
heterolog
univers
immun
across
multipl
unrel
strain
influenza
studi
assess
rel
contribut
differ
influenza
viru
protein
human
cell
respons
identifi
np
matrix
protein
major
target
suggest
cell
vaccin
may
need
focu
key
viral
protein
achiev
similar
coverag
natur
infect
focu
prime
cell
memori
conserv
protein
target
may
also
implic
reduc
interfer
haimprint
futur
vaccin
design
cell
respons
influenza
viru
differ
individu
primarili
due
express
divers
mhc
allel
known
human
human
leucocyt
antigen
hla
determin
array
viral
peptid
present
cell
recognit
given
polymorph
natur
hla
allel
fact
individu
express
six
hla
class
hlai
hlaa
b
c
six
hla
class
ii
hlaii
hladr
dq
dp
allel
potenti
vast
divers
epitop
present
recognit
infect
despit
cell
respons
usual
focu
peptid
hla
epitop
respons
epitop
typic
observ
across
individu
express
hla
allel
respons
differ
epitop
often
arrang
reproduc
immunodomin
hierarchi
wherein
defin
immunodomin
larg
subdomin
small
magnitud
rel
size
given
epitopespecif
cell
respons
reflect
complex
interplay
viru
host
factor
review
includ
particular
combin
hla
allel
express
necessarili
relat
number
epitopespecif
precursor
avail
approach
combin
vitro
infect
cell
line
mass
spectrometri
analysi
allow
direct
identif
array
peptid
present
cell
surfac
individu
hla
allel
follow
influenza
infect
date
result
show
present
reason
small
select
viru
peptid
nine
hlaa
six
b
mainli
deriv
intern
viru
protein
one
two
peptid
respect
consist
induc
immun
respons
understand
present
peptid
target
other
seemingli
ignor
remain
key
question
may
lead
strategi
optim
breadth
vaccineinduc
cell
respons
hlai
allel
express
import
predictor
crossreact
influenzaspecif
cell
immun
recent
studi
identifi
five
allel
b
b
b
capabl
elicit
robust
cell
respons
immunogen
np
peptid
conserv
across
human
influenza
viru
includ
novel
avianderiv
viru
strong
represent
protect
hla
allel
popul
therefor
predict
univers
memori
cell
respons
potenti
protect
multipl
circul
novel
influenza
viru
strain
hla
profil
herit
strongli
influenc
ethnic
extent
univers
immun
show
expect
ethnic
bia
higher
coverag
anticip
caucasian
popul
enrich
key
allel
base
hla
allel
express
compar
indigen
alaskan
indigen
australian
whilst
certain
hla
allel
may
confer
protect
advantag
univers
immun
multipl
influenza
strain
express
allel
may
increas
suscept
sever
influenza
diseas
studi
mention
also
identifi
four
hlai
allel
b
target
uniqu
np
peptid
variant
unlik
elicit
crossprotect
immun
season
infect
thu
upon
infect
individu
hla
allel
need
time
activ
amplifi
new
primari
cell
respons
distinct
peptid
variant
rather
recal
cell
respons
gener
season
influenza
virus
potenti
result
longer
time
recoveri
greater
risk
sever
diseas
compar
individu
preexist
crossprotect
cell
memori
hertz
et
al
show
hlaa
allel
also
low
bind
prefer
peptid
conserv
region
pandem
viru
carriag
allel
correl
low
influenzaspecif
cell
respons
patient
moreov
popul
level
carriag
hlaa
allel
hlaa
allel
associ
increas
mortal
risk
hla
allel
may
serv
use
marker
identifi
individu
popul
like
low
magnitud
less
crossreact
memori
cell
respons
place
greater
risk
sever
influenza
diseas
interestingli
hlaa
allel
highli
preval
certain
indigen
popul
could
explain
group
experi
higher
burden
influenza
diseas
mortal
season
pandem
influenza
howev
risk
hla
allel
may
also
indirect
effect
suscept
influenza
associ
autoimmun
metabol
disord
exampl
hlaa
associ
diabet
diseas
increas
incid
indigen
popul
nevertheless
notion
protect
andor
risk
hla
allel
demonstr
previous
human
immunodefici
viru
hiv
hepat
c
viru
hcv
clearli
emerg
factor
influenza
infect
link
part
capac
certain
hla
allel
present
conserv
protect
variabl
risk
influenza
peptid
ethnic
key
determin
risk
sever
influenza
diseas
indigen
popul
worldwid
experienc
disproportion
burden
morbid
mortal
caus
infect
influenza
virus
pandem
higher
hospit
morbid
rate
observ
indigen
peopl
canada
unit
state
new
zealand
australia
likewis
indigen
popul
experienc
higher
mortal
rate
pandem
compar
worldwid
higher
influenza
viru
infect
rate
indigen
popul
may
relat
crowd
live
condit
increas
rate
chronic
diseas
lung
heart
metabol
comorbid
exacerb
sever
infect
nevertheless
recoveri
influenza
depend
strongli
abil
mobil
multipl
arm
immun
systemin
particular
earli
cell
respons
sever
influenza
diseas
prolong
hospitalis
period
observ
indigen
peopl
may
therefor
reflect
lack
preexist
protect
cell
immun
promot
rapid
recoveri
mention
hlaa
allelesa
known
risk
factor
sever
diseas
enrich
within
sever
global
indigen
popul
indic
possibl
hlarel
defici
cell
respons
influenza
may
contribut
vulner
commun
notabl
hla
profil
indigen
australian
rel
restrict
quit
distinct
nonindigen
australian
predomin
use
hlaa
hlab
domin
cell
respons
indigen
australian
like
focu
differ
peptidehla
epitop
compar
ethnic
sinc
studi
mostli
focus
identifi
characteris
immunogen
peptid
common
wide
express
hla
allel
hlaa
immunogen
influenza
epitop
yet
defin
hlai
allel
found
indigen
australian
howev
analysi
hlaa
specif
cell
found
compar
magnitud
function
qualiti
clonal
characterist
indigen
australian
nonindigen
australian
suggest
indigen
australian
repres
popul
robust
crossprotect
cell
immun
influenza
viru
howev
accur
determin
extent
qualiti
cell
immun
indigen
australian
indigen
popul
worldwid
requir
identif
promin
cell
target
relev
indigen
hla
great
interest
see
effect
hla
elicit
influenzaspecif
cell
immun
base
hla
profil
target
respons
promin
hla
indigen
australian
could
achiev
high
level
popul
coverag
may
necessit
tailor
vaccin
mani
hla
allel
occur
rare
ethnic
clearli
much
need
done
improv
understand
influenza
viru
infect
indigen
popul
design
better
protocol
protect
popul
greater
risk
sever
influenza
diseas
death
despit
challeng
hla
divers
possibl
confound
associ
metabol
autoimmun
disord
understand
cell
respons
influenza
across
broad
rang
hla
profil
import
part
design
test
efficaci
futur
vaccin
although
respons
magnitudetyp
measur
peripheryi
undoubtedli
critic
aspect
effect
antiinfluenza
cell
immun
polyfunction
cell
respons
also
link
improv
outcom
infect
hla
genotyp
may
import
intrins
factor
shape
magnitud
function
profil
cell
respons
hlab
allel
significantli
better
hlaa
allel
gener
robust
polyfunct
cell
respons
hiv
cmv
ebv
influenza
reflect
gener
enhanc
effect
hlab
allel
also
appear
hierarchi
associ
polyfunction
amongst
hlab
allel
combin
hla
allel
express
also
impact
number
tcr
repertoir
epitopespecif
precursor
alter
peptid
present
modul
surfac
express
competit
overlap
peptid
shape
activ
prolifer
precursor
infect
context
differ
hla
profil
therefor
difficult
predict
cell
respons
hierarchi
epitop
across
hladivers
human
popul
howev
focus
largest
immunodomin
cell
respons
may
allimport
smaller
subdomin
cell
epitop
also
contribut
influenza
viru
clearanc
may
underutil
follow
natur
infect
could
har
vaccin
achiev
full
antivir
potenti
provid
broad
combin
respons
better
natur
infect
increas
breadth
antivir
respons
target
subdomin
epitop
may
also
reduc
potenti
mutat
escap
immunodomin
epitop
effect
influenza
vaccin
capit
abil
protect
hla
allel
present
univers
conserv
viral
compon
selfselect
peptid
present
elicit
broad
spectrum
cell
immun
singl
specif
peptid
vaccin
target
could
come
cost
populationwid
coverag
across
divers
hla
profil
approach
incorpor
whole
protein
antigen
like
provid
coverag
human
set
divers
hla
type
avoid
concentr
immun
pressur
may
drive
emerg
escap
mutat
target
epitop
furthermor
strategi
could
use
optim
peptid
present
risk
hla
allel
modif
extraepitop
process
site
vaccin
design
upstream
extraepitop
sequenc
alreadi
shown
alter
cell
respons
immunodomin
cell
respons
possibl
via
chang
cleavag
pattern
protein
influenc
extent
peptid
present
ideal
influenza
cellbas
vaccin
would
therefor
induc
overal
robust
respons
compris
multipl
crossreact
epitopespecif
cell
popul
high
function
qualiti
engag
multipl
immun
mechan
greater
synergi
protect
figur
would
encompass
import
hla
coverag
even
minor
ethnic
rare
hla
type
importantli
leverag
knowledg
key
epitop
crossreact
cell
respons
better
natur
influenza
rna
viru
use
errorpron
rnadepend
rna
polymeras
replic
genom
therefor
viru
abl
adapt
rapidli
infam
antigen
drift
resist
antivir
select
pressur
viru
escap
immunemedi
control
undermin
effect
vaccin
also
need
consid
cellinduc
vaccin
celltarget
protein
peptid
highli
conserv
antibodi
target
surfac
ha
variat
adapt
cell
epitop
deriv
influenza
virus
alreadi
identifi
cell
escap
observ
cell
epitop
natur
circul
influenza
virus
rais
concern
vaccinemedi
cell
escap
cell
recogn
viral
peptid
within
host
mhc
virus
mutat
mhcanchor
residu
reduc
present
altern
expos
residu
form
contact
tcr
recognit
variat
tcr
contact
site
reduc
recognit
exist
cell
respons
howev
due
tcr
divers
establish
new
cell
respons
new
peptid
variant
often
subsequ
possibl
mutat
viral
peptid
mhc
anchor
residu
tcr
contact
impact
viral
clearanc
recal
establish
heterosubtyp
memori
cell
respons
howev
concept
remain
underappreci
could
undermin
celltarget
vaccinemedi
control
previou
preliminari
data
isol
viral
rna
lung
infect
mice
show
influenza
escap
occur
earli
infect
individu
mous
common
across
individu
mice
thu
rare
event
mutat
anchor
site
tcr
contact
cell
influenza
epitop
readili
identifi
revert
absenc
epitopespecif
immun
pressur
may
suggest
hla
frequenc
popul
determin
rate
cellmedi
immun
escap
popul
sequenc
studi
drift
np
protein
identifi
posit
select
pressur
furthermor
epitop
level
anchor
mutat
identifi
hlab
b
np
epitop
evid
immun
escap
np
cell
epitop
show
epitop
function
constrain
limit
extent
variat
possibl
cell
pose
evolutionari
pressur
influenza
viru
influenza
epitop
reproduc
select
domin
public
hlaa
donor
crossrecogn
natur
occur
peptid
variant
seemingli
limit
establish
mutant
strain
within
circul
pool
human
influenza
virus
confer
univers
immun
influenza
individu
convers
immunodomin
hlab
restrict
np
epitop
differ
pattern
sequenti
viral
variat
gener
differ
peptid
variant
tcr
contact
site
cell
evas
occur
select
peptid
result
need
prime
multipl
cell
set
coverag
divers
np
variant
situat
success
wave
exposur
np
variant
may
drive
divers
uniqu
repertoir
recruit
variabl
pattern
crossreact
individu
variant
favour
rather
control
emerg
addit
mutant
therefor
preemptiv
prime
cell
subset
common
escap
variant
could
circumv
immun
escap
thu
could
incorpor
futur
vaccin
strategi
need
consid
contrast
pattern
epitop
variat
immun
select
tailor
mosaic
peptid
vaccin
might
best
way
circumv
influenza
viru
escap
popul
level
vaccin
rollout
would
impract
consid
hla
select
fulllength
protein
immun
competit
cell
prime
area
research
need
explor
np
protein
alreadi
abl
interchang
leningrad
laiv
backbon
demonstr
possibl
mosaic
approach
incorpor
cell
peptid
variant
current
method
furthermor
recent
studi
demonstr
hivinfect
children
oppos
hivinfect
adult
abl
gener
hiv
variantspecif
cell
respons
limit
select
escapeepitop
variant
earli
infect
superior
immun
respons
natur
influenza
viru
infect
also
observ
children
age
well
understood
identifi
key
window
vaccin
cell
compart
better
natur
togeth
studi
suggest
includ
common
tcr
escap
variant
epitop
cellinduc
influenza
vaccin
might
effect
young
children
could
prevent
vaccinemedi
cell
escap
overal
research
need
establish
whether
combin
cell
epitop
tcr
escap
variant
time
vaccin
benefit
cellinduc
influenza
vaccin
addit
littl
known
epitop
variat
influenza
infect
due
pauciti
defin
epitop
furthermor
data
also
lack
individu
human
viral
quasispeci
gener
infect
one
exampl
sequenc
cell
peptid
longitudin
infect
paediatr
patientderiv
viral
rna
area
research
need
expand
enabl
vaccin
design
thwart
viral
escap
recent
licensur
recombin
ha
proteinbas
vaccin
overcom
manufactur
delay
problem
eggadapt
repres
margin
improv
old
method
base
induc
hatarget
antibodi
approach
improv
breadth
vaccin
coverag
thu
new
novel
approach
toward
influenza
vaccin
consid
cell
immun
strongest
potenti
immun
correl
capabl
true
univers
paninfluenza
immun
tabl
current
effort
clinic
develop
pandem
vaccin
utilis
cell
match
potenti
prioritis
vaccin
current
develop
util
cellbas
immun
control
potenti
univers
protect
influenza
viru
infect
number
strategi
clinic
develop
figur
includ
use
vector
modifi
vaccinia
ankara
mva
simian
adenoviru
encod
intern
np
protein
influenza
adenoviru
vector
vaccin
contain
ha
alon
recombin
peptid
approach
mosaic
conserv
peptid
np
protein
viral
vector
differ
safeti
profil
recombin
protein
inactiv
vaccin
mayb
promis
approach
robust
immun
respons
potenti
better
natur
viral
vector
replic
vaccinia
adenoviru
simian
adenoviru
safe
use
immunocompromis
elderli
nonrepl
vector
includ
mva
adenovirus
influenza
minu
ha
signal
peptid
also
use
safe
everyon
promis
result
report
vaccin
boost
robust
cell
respons
adult
elderli
protect
influenza
challeng
furthermor
cellinduc
vaccin
strategi
also
assess
ferret
transmiss
model
specif
ha
minu
signal
peptid
vaccin
show
reduc
transmiss
time
peak
viral
load
vaccin
ferret
ferret
cellinduc
vaccin
target
pandem
potenti
virus
significantli
underutilis
resourc
pandem
potenti
vaccin
clinic
develop
capabl
induc
robust
cell
respons
figur
major
avian
pandem
potenti
vaccin
candid
produc
inactiv
vaccin
addit
adjuv
increas
immunogen
potenti
cell
respons
adjuv
use
nont
celltarget
vaccin
celltarget
vaccin
use
adjuv
figur
method
deliveri
cellinduc
vaccin
typic
requir
exogen
adjuv
viral
vector
selfadjuv
use
constrain
popul
elderli
young
children
pregnant
women
includ
use
adjuv
reactiv
avian
influenza
virus
subtyp
vaccin
miss
input
defin
exclud
b
proport
total
vaccin
denot
vaccin
design
stimul
cell
respons
squaleneoilinwaterbas
adjuv
ie
licens
use
inactiv
influenza
vaccin
europ
us
report
improv
cell
respons
vaccin
presum
robust
stimul
innat
immun
respons
lead
enhanc
antigen
present
iiv
induc
igg
isotyp
switch
cellindepend
manner
still
induc
robust
cell
respons
relationship
may
exploit
context
cell
imprint
also
suggest
adjuv
improv
cell
respons
vaccin
ferret
inactiv
vaccin
elicit
stronger
cell
respons
upon
viru
challeng
compar
unadjuv
vaccin
howev
adjuv
effect
cell
popul
human
limit
care
must
also
taken
appli
infer
anim
data
human
set
major
anim
studi
use
anim
test
vaccin
respons
wherea
youngest
human
popul
influenza
viru
consensu
accept
level
protect
cell
vaccin
need
consid
context
pandem
prepared
threat
zoonot
infect
whilst
immun
induc
may
steril
vaccin
reduc
symptom
length
sever
infect
prevent
death
hospit
potenti
decreas
transmiss
commun
may
bring
suffici
health
econom
benefit
worthwhil
target
heterolog
cell
respons
induc
broad
protect
divers
influenza
viru
strain
subtyp
greater
knowledg
influenza
epitop
recognis
cell
need
defin
univers
conserv
viru
compon
elicit
broad
spectrum
cell
immun
incorpor
cell
vaccin
provid
populationwid
coverag
across
divers
hla
profil
ethnic
approach
incorpor
whole
protein
antigen
complet
viru
rather
select
peptid
employ
strategi
optim
peptid
present
boost
respons
subdomin
epitop
eg
modif
extraepitop
process
site
consid
tailor
vaccin
design
ethnic
uniqu
risk
hla
profil
place
high
risk
sever
influenza
diseas
circumv
viru
escap
cell
immun
spread
immun
pressur
multipl
epitop
use
full
protein
whole
viru
preemptiv
prime
cell
subset
common
escap
variant
young
age
combin
immun
mechan
induct
stem
antibodi
reduc
immun
pressur
cell
epitop
establish
local
immun
site
infect
seed
durabl
effect
trm
memori
popul
lung
upper
respiratori
tract
requir
local
ie
intranas
administr
antigen
work
need
determin
lifespan
stabil
human
lung
airway
trm
potenti
provid
durabl
vaccin
memori
synerg
multipl
immun
mechan
combin
longlast
broadlyreact
b
cell
immun
cell
vaccin
use
combin
improv
antibodi
vaccin
target
method
induc
multipl
respons
eg
peripher
cell
lungresid
trm
fh
cell
memori
b
cell
crossreact
stemspecif
antibodi
combinatori
vaccin
import
consid
longterm
effect
vaccin
imprint
cell
b
cell
respons
particularli
face
everevolv
influenza
virus
addit
broadli
protect
cell
vaccin
variou
vaccin
strategi
elicit
hastemspecif
antibodi
current
develop
review
howev
high
concentr
hastemspecif
antibodi
requir
induc
steril
immun
failur
induc
high
enough
hastemspecif
antibodi
titr
individu
combin
continu
immun
pressur
region
rest
popul
could
eventu
lead
unforeseen
hastem
escap
mutat
univers
influenza
vaccin
strategi
greatli
benefit
addit
layer
longlast
broadlyreact
immun
form
cell
compon
dampen
sever
limit
spread
influenza
viru
manag
escap
ha
stemspecif
antibodi
respons
reciproc
induct
addit
hastemspecif
antibodi
vaccin
could
help
prevent
vaccinemedi
cell
escap
natur
influenza
virus
neutral
establish
infect
limit
exposur
cell
immun
pressur
true
univers
influenza
vaccin
would
combin
best
world
onetwo
punch
influenza
virus
review
highlight
underappreci
aspect
influenzaspecif
cell
immun
consider
design
univers
vaccin
futur
tabl
includ
caveat
potenti
short
halflif
cell
resid
memori
cell
immun
escap
impact
antigen
present
time
immunodomin
hierarchi
context
hla
allel
populationwid
coverag
research
need
cell
field
identifi
protect
capac
optim
vaccin
design
safe
deliveri
result
longest
durat
effect
memori
popul
statist
model
predict
cellinduc
vaccin
like
effect
antibodi
cellprim
subject
infect
season
virus
wider
efficaci
trial
need
combin
clinic
data
anoth
challeng
face
cellinduc
vaccin
need
improv
standard
care
provid
current
inactiv
vaccin
inactiv
vaccin
vaccin
vector
contain
influenza
viral
protein
elicit
differ
immun
correl
protect
far
compar
headtohead
largescal
efficaci
trial
unfortun
forese
futur
role
cell
mediat
protect
infect
still
fundament
discuss
use
cellinduc
vaccin
requir
standardis
assay
assess
cell
memori
hai
assay
rel
simpl
rudimentari
measur
virusspecif
antibodi
use
year
well
standardis
contrast
studi
influenzaspecif
cell
memori
respons
human
subject
undoubtedli
technicallydemand
resourc
heavi
compar
serolog
approach
current
concert
effort
toward
standard
streamlin
experiment
approach
cell
assay
vaccin
studi
although
like
take
time
standard
cell
assay
identifi
cell
vast
potenti
breadth
recognit
influenza
virus
field
rel
infanc
compar
antibodybas
vaccin
quantum
leap
need
adapt
vaccin
product
safeti
efficaci
trial
standardis
assay
assess
larg
efficaci
trial
scale
realiz
author
declar
conflict
interest
